Treatment of MEC1, EHEB and JVM2 leukemia cell lines with fludarabine, ibrutinib and idelalisib
Ontology highlight
ABSTRACT: Treatment of MEC1, EHEB and JVM2 leukemia cell lines with fludarabine, ibrutinib and idelalisib
PROVIDER: PRJNA557198 | ENA |
REPOSITORIES: ENA
ACCESS DATA